Recurrent deletions of the TNFSF7 and TNFSF9 genes in 19p13.3 in diffuse large B-cell and Burkitt lymphomas

International Journal of Cancer

Volumn 131, Issue 5, 2012, Pages

  Scholtysik, René ^a   Nagel, Inga ^b   Kreuz, Markus ^c   Vater, Inga ^b   Giefing, Maciej ^b,d   Schwaenen, Carsten ^e   Wessendorf, Swen ^e   Trümper, Lorenz ^f   Loeffler, Markus ^c   Siebert, Reiner ^b   Kup̈pers, Ralf ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d INSTITUTE OF HUMAN GENETICS   (Poland)

^e UNIVERSITY HOSPITAL ULM   (Germany)

^f UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

41BBL; CD70; Diffuse large B cell lymphoma; TNFSF7; TNFSF9; Tumor suppressor gene

Indexed keywords

AGED; ALLELE; ARTICLE; BURKITT LYMPHOMA; CHILD; CHROMOSOME 19P; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EXON; FEMALE; GENE DELETION; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR NECROSIS FACTOR SUPERFAMILY 7 GENE; TUMOR NECROSIS FACTOR SUPERFAMILY 9 GENE; TUMOR SUPPRESSOR GENE;

4-1BB LIGAND; AGED; AGED, 80 AND OVER; ANTIGENS, CD70; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 19; COMPARATIVE GENOMIC HYBRIDIZATION; DNA, NEOPLASM; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84863223864     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27416     Document Type: Article

References (25)

1. Swerdlow SH. International Agency for Research on Cancer. WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. Lyon, France: International Agency for Research on Cancer, 2008.
2. Hartmann EM, Ott G, Rosenwald A. Molecular biology and genetics of lymphomas. Hematol Oncol Clin North Am 2008;22:807-23, vii.
3. Sweetenham JW. Molecular signatures in the diagnosis and management of diffuse large B-cell lymphoma. Curr Opin Hematol 2011;18:288-92.
4. Hecht JL, Aster JC. Molecular biology of Burkitt's lymphoma. J Clin Oncol 2000;18:3707-21.
5. Scholtysik R, Kreuz M, Klapper W, Burkhardt B, Feller AC, Hummel M, Loeffler M, Rosolowski M, Schwaenen C, Spang R, Stein H, Thorns C, et al. Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis. Haematologica 2010;95:2047-55.
6. Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF, Bernd HW, Cogliatti SB, Dierlamm J, Feller AC, Hansmann ML, Haralambieva E, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006;354:2419-30. (Pubitemid 43855045)
7. Klapper W, Szczepanowski M, Burkhardt B, Berger H, Rosolowski M, Bentink S, Schwaenen C, Wessendorf S, Spang R, Moller P, Hansmann ML, Bernd HW, et al. Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood 2008;112:1374-81.
8. Schwaenen C, Viardot A, Berger H, Barth TF, Bentink S, Dohner H, Enz M, Feller AC, Hansmann ML, Hummel M, Kestler HA, Klapper W, et al. Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status. Genes Chromosomes Cancer 2009;48:39-54.
9. Kreuz M, Rosolowski M, Berger H, Schwaenen C, Wessendorf S, Loeffler M, Hasenclever D. Development and implementation of an analysis tool for array-based comparative genomic hybridization. Methods Inf Med 2007;46:608-13. (Pubitemid 47598982)
10. Affymetrix. BRLMM: an improved genotype calling method for the genechip human mapping 500k array set. Technical Report, White Paper. Santa Clara, CA: Affymetrix, 2006.
11. Nannya Y, Sanada M, Nakazaki K, Hosoya N, Wang L, Hangaishi A, Kurokawa M, Chiba S, Bailey DK, Kennedy GC, Ogawa S. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 2005;65:6071-9. (Pubitemid 40994391)
12. Salaverria I, Philipp C, Oschlies I, Kohler CW, Kreuz M, Szczepanowski M, Burkhardt B, Trautmann H, Gesk S, Andrusiewicz M, Berger H, Fey M, et al. Translocations activating IRF4 identify a subtype of germinal center-derived Bcell lymphoma affecting predominantly children and young adults. Blood 2011;118:139-47.
13. Martin-Subero JI, Harder L, Gesk S, Schlegelberger B, Grote W, Martinez-Climent JA, Dyer MJ, Novo FJ, Calasanz MJ, Siebert R. Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci. Int J Cancer 2002;98:470-4. (Pubitemid 34188693)
14. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, Cline MS, Goldman M, Barber GP, Clawson H, Coelho A, Diekhans M, Dreszer TR, et al. The UCSC Genome Browser database: update 2011. Nucleic Acids Res 2010;39:D876-82.
15. Giefing M, Arnemann J, Martin-Subero JI, Nielander I, Bug S, Hartmann S, Arnold N, Tiacci E, Frank M, Hansmann ML, Kuppers R, Siebert R. Identification of candidate tumour suppressor gene loci for Hodgkin and Reed- Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines. Br J Haematol 2008;142:916-24.
16. Berger AH, Knudson AG, Pandolfi PP. A continuum model for tumour suppression. Nature 2011;476:163-9.
17. Taraban VY, Rowley TF, Tough DF, Al- Shamkhani A. Requirement for CD70 in CD4+Th cell-dependent and innate receptor-mediated CD8+ T cell priming. J Immunol 2006;177:2969-75. (Pubitemid 44277812)
18. Laderach D, Wesa A, Galy A. 4-1BB-ligand is regulated on human dendritic cells and induces the production of IL-12. Cell Immunol 2003;226:37-44. (Pubitemid 38121296)
19. Dolfi DV, Boesteanu AC, Petrovas C, Xia D, Butz EA, Katsikis PD. Late signals from CD27 prevent Fas-dependent apoptosis of primary CD8+ T cells. J Immunol 2008;180:2912-21.
20. Arens R, Schepers K, Nolte MA, van Oosterwijk MF, van Lier RA, Schumacher TN, van Oers MH. Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation. J ExpMed 2004;199:1595-605. (Pubitemid 38780414)
21. Kim Y, Strehl JW, Gorschluter M, Ziske C, Schmidt-Wolf IG. Prevention of lethal tumor growth and generation of long-lasting immunity in vivo using CD137L and interleukin-12 gene transfer. In Vivo 2008;22:337-43.
22. Grunebach F, Kayser K, Weck MM, Muller MR, Appel S, Brossart P. Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes. Cancer Gene Ther 2005;12:749-56. (Pubitemid 41208614)
23. Vinay DS, Choi BK, Bae JS, Kim WY, Gebhardt BM, Kwon BS. CD137-deficient mice have reduced NK/NKT cell numbers and function, are resistant to lipopolysaccharide-induced shock syndromes, and have lower IL-4 responses. J Immunol 2004;173:4218-29. (Pubitemid 39280788)
24. Middendorp S, Xiao Y, Song JY, Peperzak V, Krijger PH, Jacobs H, Borst J. Mice deficient for CD137 ligand are predisposed to develop germinal center-derived B-cell lymphoma. Blood 2009;114:2280-9.
25. Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A, Wells VA, Grunn A, Messina M, Elliot O, Chan J, Bhagat G, et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 2011;43:830-7.